Vascular protection in outpatient angiology: focus on regulatory peptides

Alekperova T.V.

doi:https://doi.org/10.17116/kardio202417051581

Close metadata

Recommended articles:

Modern approach to the treatment of acute iliofemoral thrombosis. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(3):293-299

Bacterial cellulose-based materials in medicine. Medical Technologies. Assessment and Choice. 2025;(1):84-91

Current approaches to the prevention and treatment of post-thrombotic syndrome. Russian Journal of Preventive Medicine. 2025;(5):111-116

Targets of rational neuroprotection in the therapy of chronic cerebral ischemia and the possibilities of achieving them. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):96-101

Early antithrombotic protection of the brain in patients with ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):5-10

Cyanoacrylate Glue Ablation of Perforating Veins in Patients with Recurrent Varicose Veins of the Lower Extremities: A Prospective Study. Journal of Venous Disorders. 2025;(3):192-197

Mechanical Endovascular Thromboextraction and Catheter-Directed Thrombolysis in Patients with Iliofemoral Deep Vein Thrombosis of the Lower Extremities: a Single-Center Prospective Cohort Study. Journal of Venous Disorders. 2025;(3):198-205

Abstract:

To date, angiology suggests innovative methods of outpatient diagnosis and treatment that expands the prospects for personalized vascular care. The main pathogenetic approach in outpatient practice remains prevention and treatment of endothelial dysfunction. Personalized characteristics of endothelial damage, necessary for emergency care, become available after outpatient vascular ultrasound. These data are valuable for target therapy of endothelial dysfunction. Slavinorm based on vascular regulatory peptides has an exclusive effect on vascular endothelium among modern drugs. We present a patient with clinical deterioration after previous vein diseases. Vascular ultrasound revealed endothelial damage affecting lower limb arteries. A positive result was achieved after monotherapy with Slavinorm.

Keywords:

outpatient angiology

CEAP classification

focused ultrasound examination of vessels

ultrasound markers of endothelial dysfunction

recurrent varicose veins

neoangiogenesis

trophic ulcers

post-thrombotic syndrome

incompetent muscular-venous «pump»

lymphostasis

chronic diseases of lower limb arteries

atherothrombosis

vascular protector

vascular polypeptides

Slavinorm

Authors:

Alekperova T.V.

Institute of Interdisciplinary Medicine

Received:

11.09.2024

Accepted:

28.09.2024

Close metadata

References:

Kirienko AI, Koshkin VM, Bogachev VYu. Outpatient Angiology. Guide for Physicians. M.: Litterra, 2007. (In Russ.).
Saveliev VS. Phlebology. Guide for doctors. M.: Medicine, 2001. (In Russ.).
Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;(382):1329-1340.
Kharazov AF, Kalyaev AO, Isaev AA. PAD prevalence In Russian Federation. Pirogov Russian Journal of Surgery. 2016;(7):58-61. (In Russ.). https://doi.org/10.17116/hirurgia2016758-61.
Itoga NK, Minami HR, Chelvakumar M, Pearson K, Mell MM, Bendavid E, et al. Cost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI test. Vasc Med. 2018;23(2):97-106. https://doi.org/10.1177/1358863X17745371.
Kalinin RE, Suchkov IA, Klimentova EA, et al. Markers of apoptosis, cell proliferation, endothelial dysfunction in atherosclerosis of lower extremity arteries. Bulletin of the National Medical and Surgical Center named after N.I. Pirogov. 2021;16(1):25-32. (In Russ.). https://doi.org/10.25881/BPNMSC.2021.26.94.005
Dunaevskaya SS, Vinnik YuS. Development of endothelial dysfunction in obliterating atherosclerosis of the lower extremity vessels and markers for predicting the course of the disease. Bulletin of Siberian Medicine. 2017;16(1):108-118. (In Russ.). https://doi.org/10.20538/1682-0363-2017-1-108-118
Shevchenko YuL, Stoyko YuM, Lytkina MI. Fundamentals of clinical phlebology. M.: Medicine, 2005. (In Russ.).
Pokrovsky AV, Sapelkin SV. Chronic venous insufficiency of the lower extremities — modern problems of diagnostics, classification, treatment. Angiology and vascular surgery. 2003;9(1):53-60. (In Russ.).
Shevchenko YuL, Stoyko YuM, Gudymovich VG, et al. Dysfunction of the endothelium in patients with varicose veins of the lower extremities and the possibilities of its correction. Angiology and vascular surgery. 2010;16(4):99-104. (In Russ.).
Shevchenko JuL, Astashev PE, Matveev SA, Goodymovich VG. Endothelium — structural basis of circulatory system: the history of the problem. Bulletin of Pirogov National Medical and Surgical Center. 2011;6(2):9-15. (In Russ.).
Simonova OG, Kolobova OI, Leshchenko VA. The regional orthostatic mechanisms of endothelial dysfunction associated with primary varicose veins. Journal of Venous Disorders. 2014;8(4):25-28. (In Russ.).
https://doi.org/10.23888/HMJ2023112241-256. https://doi.org/HMJ2023112241-256
Shevchenko IuL, Stoiko IuM, Gudymovich VG, et al. Glycocalyx as a determining factor in development of endothelial venous dysfunction and possibilities of correction thereof. Angiology and Vascular Surgery. 2020;26(4):71–7. (In Russ). https://doi.org/10.33529/ANGIO2020404
Safonov VA, Gromatsky DF, Nenarochnov SV, Sherov RKh. Recurrence of varicose veins. Causes, methods of diagnosis and treatment. Bulletin of the Siberian Branch of the Russian Academy of Medical Sciences. 2013;33:3. (In Russ.).
Stoyko YuM. Postoperative recurrence of varicose veins. Abstract of dis. … d-r of med. sciences. L. 1990;39. (In Russ.).
Perrin M. Presence of varicose after operative treatment: a review (Part 2) (Chassieu, France). Phlebolymphology. 2015;22(1):51.
Gavrilenko AV, Vakhratyan PE, Oskolkova SA. Causes of recurrence of varicose veins of the lower extremities. Annals of surgery. 2013;1:10-15. (In Russ.).
Lurie F, Passman M, Meisner M, et al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord. 2020;8(3):342-352. https://doi.org/10.1016/j.jvsv.2019.12.075.Epub2020Feb27
Abdurakhmanov ZM, Umarov BY, Abdurakhmanov MM. Novel Biomarkers of Endothelial Dysfunction in Cardiovascular Diseases. Rational Pharmacotherapy in Cardiology. 2021;17(4):612-618. (In Russ.). https://doi.org/10.20996/1819-6446-2021-08-08
Shabrov AV, Apresyan AG, Dobkes AL, et al. Modern methods of endothelial dysfunction assessment and their application in practical medicine. Rational pharmacotherapy in cardiology. 2016;12(6):733-742. (In Russ.). https://dx.doi.org/10.20996/1819-6446-2016-733-742
Balakhonova TV, Ershova AI, Ezhov MV, et al. Focused vascular ultrasound. Consensus of Russian experts. Cardiovascular Therapy and Prevention. 2022;21(7):3333. (In Russ.). https://doi.org/10.15829/1728-8800-2022-3333
Balakhonova TV, Tripoten MY, Pogorelova OA. Ultrasonic methods of an assessment of intima-media thickness of an arterial wall. SonoAce Ultrasound. 2010;21:57-63. (In Russ.).
Torres-Macho J, Aro T, Bruckner I, et al. Point-of-care ultrasound in internal medicine: A position paper by the ultrasound working group of the European federation of internal medicine. Eur J Intern Med. 2020;73:67-71. https://doi.org/10.1016/j.ejim.2019.11.016.
Kakkos SK, Gohel M, Baekgaard N, et al. Editor’s Choice — European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. Eur J Vasc Endovasc Surg. 2021;61(1):9-82. https://doi.org/10.1016/j.ejvs.2020.09.023.
Khavinson VK. Peptide medicines: past, present, future. Clinical Medicine. 2020;98(3):165-177. (In Russ.). https://doi.org/10.30629/0023-2149-2020-98-3-165-177
Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nat Rev Drug Discov. 2021;20(4):309-325. https://doi.org/10.1038/s41573-020-00135-8
Suchkov IA, Kalinin RE, Mzhavanadze ND, et al. Efficacy and safety of the drug based on regulatory vascular polypeptides for the treatment of intermittent claudication (results of a multicenter double-blind placebo-controlled randomized trial). Angiology and vascular surgery. 2023;29(1):25-29. (In Russ.).
Khochenkova YuA, Khochenkov DA, Korzhova KV, et al. Angioprotective and Regenerative Potential of the Polypeptide Drug Slavinorm in Endothelial Dysfunction and Atherosclerotic Vascular Lesions. Effective pharmacotherapy. 2023;19(5):24-31. (In Russ.). https://doi.org/10.33978/2307-3586-2023-19-5-24-31
«Slavinorm» is an innovative drug for the pathogenetic treatment of obliterating diseases of the arteries of the lower extremities. Resolution of the Expert Council 25.08.2022. Pirogov Russian Journal of Surgery. 2022;10:105-106. (In Russ.). https://doi.org/10.17116/hirurgia2022101105